| Group and Company | Number of shares millions |
Ordinary shares |
Share |
Total £m |
||
| At 1 April 2006 | 118.3 | 14.5 | 34.7 | 49.2 | ||
| Shares issued | – | – | – | – | ||
| At 31 March 2007 | 118.3 | 14.5 | 34.7 | 49.2 | ||
| Shares issued | 5.8 | 0.7 | 5.7 | 6.4 | ||
| At 31 March 2008 | 124.1 | 15.2 | 40.4 | 55.6 |
The total authorised number of ordinary shares is 196,363,620 shares (2007: 196,363,620 shares) with a par value of 12.2 pence per share (2007: 12.2 pence per share). All issued shares are fully paid.
On 26 July 2007 the Company successfully placed 5,814,610 new ordinary shares at a price of 115.0 pence per share raising £6.7 million before expenses (£6.4 million net of expenses). The funds raised will be used to help the Company grow the business both organically and by acquisition and will provide greater financial flexibility. The shares were admitted to the Official List and commenced trading on 1 August 2007.
Warrants
The placing of new ordinary shares in July 2007 entitled the holders of the Company’s warrant instruments to additional shares on exercise of those warrants. The Company has in issue 5,987,560 warrants (2007: 5,707,047) giving the holders the right to subscribe in cash for shares in the Company.
Holders of individual ‘A’ warrants may subscribe for one ordinary share in the Company at a price of 65 pence and these warrants may be exercised at any time prior to 8 July 2008 (1,620,761 warrants) and any time prior to 8 July 2010 (3,056,760 warrants). Holders of individual ‘B’ warrants may subscribe for one ordinary share in the Company at a price of 109 pence and these warrants may be exercised at any time prior to 31 May 2009 (1,310,039 warrants). The fair value of these warrants as at 31 March 2008, calculated by reference to a closing market price of 70.00 pence per share is £0.2 million (2007: £1.8 million, calculated by reference to the closing market price of 106.25 pence).
Employee share schemes – all employee share plans
The Group operates UK Save As You Earn (“SAYE”) schemes whereby employees are given the opportunity to apply for options in ordinary shares of the Company. Options are granted at a price 20% below the market price ruling at the date of grant. Grants are exercisable after three or five years of savings by the employees. All options will be equity settled.
| Period of option | Number of shares 2008 |
Number of shares 2007 |
Subscription price per share Pence |
|
| 1 March 2007 to 31 August 2007 | – | 48,660 | 196 | |
| 1 April 2007 to 30 September 2007 | – | 84,458 | 187 | |
| 1 April 2008 to 30 September 2008 | 48,981 | 77,432 | 127 | |
| 1 April 2008 to 30 September 2008 | 118,752 | 144,371 | 125 | |
| 1 April 2009 to 30 September 2009 | 20,273 | 22,196 | 187 | |
| 1 April 2009 to 30 September 2009 | 241,377 | 357,919 | 96 | |
| 1 April 2010 to 30 September 2010 | 46,898 | 59,852 | 125 | |
| 1 April 2010 to 30 September 2010 | 351,369 | 422,001 | 80 | |
| 1 April 2011 to 30 September 2011 | 52,183 | 109,201 | 96 | |
| 1 April 2011 to 30 September 2011 | 391,756 | – | 70 | |
| 1,271,589 | 1,326,090 |
Employee share schemes – discretionary share plans
The Group operates long–term incentive plans for senior managers and Directors. Details of the Company Share Option Plans (“CSOP”) and Performance Share Plans (“PSP”) are given below and in the Report on Directors’ remuneration. All CSOP options will be equity settled. For the PSP scheme the exercise price is nil.
| CSOP Scheme |
Performance period | Outstanding options at 31 March 2008 |
Outstanding options at 31 March 2007 |
Option price Pence |
|
| 2001 | 1 April 2001 to 31 March 2004 | 256,647 | 596,011 | 296.5 | |
| 2001 | 1 April 2001 to 31 March 2004 | – | 94,537 | 238.0 | |
| 256,647 | 690,548 |
| PSP Scheme | Performance period | Outstanding options at 31 March 2008 |
Outstanding options at 31 March 2007 |
||
| 2004 | 18 August 2004 to 17 August 2007 | – | 738,757 | ||
| 2005 | 8 July 2005 to 7 July 2008 | 875,902 | 918,024 | ||
| 2005 | 19 July 2005 to 18 July 2008 | 194,037 | 194,037 | ||
| 2005 | 8 December 2005 to 7 December 2008 | 14,791 | 14,791 | ||
| 1,084,730 | 1,865,609 |
Options outstanding – SAYE
| 2008 | 2007 | |||||
| Options No. |
Average |
Options |
Average exercise price Pence |
|||
| At 1 April | 1,326,090 | 108.2 | 3,686,223 | 124.2 | ||
| Granted in year | 397,241 | 70.0 | 431,215 | 80.0 | ||
| Exercised in year | (20,672) | 95.3 | (32,688) | 97.0 | ||
| Forfeited in year | (431,070) | 127.2 | (2,758,660) | 125.3 | ||
| At 31 March | 1,271,589 | 68.4 | 1,326,090 | 108.2 | ||
| Exercisable as at 31 March | – | – | 123,774 | 126.6 | ||
Options outstanding – CSOP
| 2008 | 2007 | |||||
| Options No. |
Average |
Options |
Average exercise price Pence |
|||
| At 1 April | 690,548 | 288.5 | 1,694,556 | 276.0 | ||
| Lapsed in year | (433,901) | 283.8 | (1,004,008) | 267.1 | ||
| At 31 March | 256,647 | 296.5 | 690,548 | 288.5 | ||
| Exercisable as at 31 March | 256,647 | 296.5 | 690,548 | 288.5 | ||
No CSOP options were exercised during the years ended 31 March 2007 and 2008.
Options outstanding – PSP
| 2008 | 2007 | |||||
| Options No. |
Average |
Options |
Average exercise price Pence |
|||
| At 1 April | 1,865,609 | – | 3,152,819 | – | ||
| Lapsed in year | (780,879) | – | (1,287,210) | – | ||
| At 31 March | 1,084,730 | – | 1,865,609 | – | ||
| Exercisable as at 31 March | – | – | – | – | ||
The fair value of SAYE options granted during the year was 43.7 pence (2007: 59.2 pence), as determined using the Black–Scholes model. The inputs into the model for the SAYE schemes are as follows:
| 2008 | 2007 | ||
| Weighted average share price at the grant date | 87p | 112p | |
| Exercise price | 70p | 80p | |
| Expected volatility | 60.0% | 56.0% | |
| Expected life | 3.0 years | 3.0 years | |
| Risk-free interest rate | 4.3% | 5.4% | |
| Expected dividend yield | 0.0% | 0.0% |
Expected volatility was determined by calculating the historical volatility of the Group’s share price over the previous 3 years. The expected life used in the model has been adjusted, based on management’s best estimates, for the effects of non–transferability, exercise restrictions and behavioural considerations.
The Group recognised total expenses of £0.1 million (2007: £0.2 million) related to equity–settled share based payment transactions.